Kerala Ayurveda Limited Schedules Extraordinary General Meeting for March 14, 2026 to Consider Preferential Equity Share Issuance

2 min read     Updated on 19 Feb 2026, 08:12 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Kerala Ayurveda Limited has scheduled an extraordinary general meeting for March 14, 2026, to consider preferential equity share issuances totaling Rs. 30.66 crore. The proposals include issuing 6,30,000 shares to promoter group entity Katra Holding Private Limited for Rs. 20,66,33,700 to convert existing loans, and 3,04,887 shares worth Rs. 9,99,99,887.13 for acquiring additional 26% stake in subsidiary Ayurvedagram Heritage Wellness Centre Private Limited. The meeting will also address amendments to the company's ESOP 2023 plan.

33057736

*this image is generated using AI for illustrative purposes only.

Kerala Ayurveda Limited has announced an extraordinary general meeting (EGM) scheduled for Saturday, March 14, 2026, at 11:00 AM (IST) through video conferencing to consider significant preferential equity share issuances totaling Rs. 30.66 crore.

Key Agenda Items

The EGM will address three special business items, with the primary focus on two major preferential equity share issuances designed to strengthen the company's financial position and consolidate its subsidiary operations.

Loan Conversion Through Equity Issuance

The first proposal involves issuing 6,30,000 equity shares at Rs. 327.99 per share to Katra Holding Private Limited, a promoter group entity. This issuance will partially adjust the existing unsecured loan of Rs. 42,23,19,290, with the equity shares worth Rs. 20,66,33,700 being used to reduce the company's debt burden.

Parameter: Details
Allottee: Katra Holding Private Limited
Category: Promoter Group
Number of Shares: 6,30,000
Price per Share: Rs. 327.99
Total Amount: Rs. 20,66,33,700
Purpose: Loan conversion

Subsidiary Acquisition Through Share Swap

The second proposal focuses on acquiring additional shareholding in Ayurvedagram Heritage Wellness Centre Private Limited, currently a 74% subsidiary. The company will issue 3,04,887 equity shares at Rs. 327.99 per share to Mr. SK Arun Kumar and Mrs. Sangeetha Arunkumar, representing a total consideration of Rs. 9,99,99,887.13.

Parameter: Details
Mr. SK Arun Kumar Shares: 1,52,444
Mrs. Sangeetha Arunkumar Shares: 1,52,443
Total Shares: 3,04,887
Price per Share: Rs. 327.99
Total Consideration: Rs. 9,99,99,887.13
Acquisition Percentage: 26% of Ayurvedagram

Pricing and Regulatory Compliance

The issue price of Rs. 327.99 per equity share has been determined in accordance with SEBI (ICDR) Regulations, based on the higher of the 90-day volume weighted average price (Rs. 327.99) or the 10-day volume weighted average price (Rs. 249.60) preceding the relevant date of February 12, 2026.

ESOP Plan Amendment

The third agenda item involves amending the Kerala Ayurveda Employee Restricted Stock Unit Plan 2023. The proposed change would modify clause 7.3 to allow the Nomination and Remuneration Committee greater flexibility in granting options equal to or exceeding 1% of the issued share capital to eligible employees, subject to separate shareholder approval.

Post-Issue Shareholding Impact

Following the preferential issuances, the company's shareholding structure will see significant changes:

Category: Pre-Issue Shares Pre-Issue % Post-Issue Shares Post-Issue %
Promoter Holding: 39,97,026 33.14% 46,27,026 35.61%
Non-Promoter Holding: 80,63,172 66.86% 83,68,059 64.39%
Total: 1,20,60,198 100.00% 1,29,95,085 100.00%

Meeting Logistics

The EGM will be conducted entirely through video conferencing in compliance with MCA circulars. Shareholders can participate in remote e-voting from March 11, 2026, at 9:00 AM to March 13, 2026, at 5:00 PM. The cut-off date for voting eligibility is February 6, 2026.

Strategic Rationale

The board believes these proposals will strengthen the company's financial position by reducing liabilities, increasing the capital base, and making Ayurvedagram a wholly-owned subsidiary. This consolidation is expected to enhance market capitalization and create greater value for shareholders through improved operational synergies and financial reporting benefits.

Historical Stock Returns for Kerala Ayurveda

1 Day5 Days1 Month6 Months1 Year5 Years
-0.15%-6.45%-23.10%-55.11%-26.24%+371.94%

Kerala Ayurveda Board Approves Q3FY26 Results, ₹30.66 Crore Preferential Issue & Subsidiary Acquisition

3 min read     Updated on 09 Feb 2026, 05:16 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Kerala Ayurveda Limited's board meeting on February 12, 2026 resulted in approval of Q3FY26 financial results, a significant ₹30.66 crore preferential equity issue comprising loan conversion and subsidiary acquisition payments, and strategic moves to make Ayurvedagram a wholly owned subsidiary, with EGM scheduled for March 14, 2026.

32183178

*this image is generated using AI for illustrative purposes only.

Kerala Ayurveda Limited's Board of Directors concluded their meeting on February 12, 2026, approving significant financial results and strategic corporate actions. The board meeting, which commenced at 12:00 PM and concluded at 3:30 PM, addressed key agenda items including quarterly financial results and major equity transactions.

Board Meeting Outcomes

The board approved several critical matters during their February 12, 2026 meeting:

Agenda Item: Details
Financial Results: Unaudited standalone and consolidated results for Q3FY26 and nine months ended December 31, 2025
Preferential Issue: 9,34,887 equity shares worth ₹30,66,33,587.13 in two tranches
Subsidiary Acquisition: 26% stake in Ayurvedagram Heritage Wellness Centre Private Limited
EGM Date: March 14, 2026 for shareholder approvals
ESOP Grant: 12,868 stock options under Employee Restricted Stock Unit Plan 2023

Financial Performance Q3FY26

The company's unaudited financial results for the quarter and nine months ended December 31, 2025 show mixed performance across standalone and consolidated operations:

Standalone Results

Metric: Q3FY26 Q3FY25 Nine Months FY26 Nine Months FY25
Revenue from Operations: ₹22.07 crores ₹19.35 crores ₹60.92 crores ₹53.34 crores
Total Income: ₹23.04 crores ₹19.48 crores ₹74.15 crores ₹54.14 crores
Net Loss: ₹3.47 crores ₹0.08 crores ₹6.81 crores ₹1.92 crores
EPS: ₹(3.03) ₹(0.13) ₹(5.76) ₹(2.16)

Consolidated Results

Metric: Q3FY26 Q3FY25 Nine Months FY26 Nine Months FY25
Revenue from Operations: ₹32.96 crores ₹31.13 crores ₹96.41 crores ₹89.01 crores
Total Income: ₹34.09 crores ₹31.36 crores ₹108.71 crores ₹90.10 crores
Net Loss: ₹4.60 crores ₹2.70 crores ₹8.93 crores Profit ₹1.41 crores
EPS: ₹(3.69) ₹(2.40) ₹(7.29) ₹0.70

Preferential Issue Details

The board approved a two-tranche preferential issue totaling 9,34,887 equity shares:

Tranche 1: Loan Conversion

Parameter: Details
Shares: 6,30,000 equity shares
Face Value: ₹10 per share
Issue Price: ₹327.99 per share
Total Value: ₹20,66,33,700
Purpose: Conversion of unsecured loan from Katra Holding Private Limited
Post-Issue Holding: 4.96% shareholding

Tranche 2: Subsidiary Acquisition

Parameter: Details
Shares: 3,04,887 equity shares
Issue Price: ₹327.99 per share
Total Value: ₹99,999,887.13
Recipients: Mr. S.K. Arun Kumar and Mrs. Sangeetha Arunkumar
Purpose: Acquisition of 26% stake in Ayurvedagram Heritage Wellness Centre

Ayurvedagram Acquisition Strategy

The company approved acquiring the remaining 26% stake in Ayurvedagram Heritage Wellness Centre Private Limited, making it a wholly owned subsidiary. Ayurvedagram's recent financial performance shows:

Financial Year: Revenue (₹ Crores)
FY 2024-25: 13.42
FY 2023-24: 11.69
FY 2022-23: 9.04

Regulatory Compliance and Next Steps

The company has scheduled an Extraordinary General Meeting on March 14, 2026, to seek shareholder approval for the preferential issues. The relevant date for determining the floor price has been set as February 12, 2026, in accordance with SEBI (ICDR) Regulations, 2018.

The Nomination and Remuneration Committee also approved granting 12,868 stock options under the Kerala Ayurveda Employee Restricted Stock Unit Plan 2023 to eligible employees at ₹10 per option, exercisable within one year.

Historical Stock Returns for Kerala Ayurveda

1 Day5 Days1 Month6 Months1 Year5 Years
-0.15%-6.45%-23.10%-55.11%-26.24%+371.94%

More News on Kerala Ayurveda

1 Year Returns:-26.24%